Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Breakthrough Mineralocorticoid Receptor Agonists in Cardiovascular Care
Author(s): Javed Butler , Dinesh Khullar , John JV McMurray , et al Added: 6 months ago
In this expert-led webinar moderated by Dr Vijay Chopra, leading clinicians review current and emerging strategies in aldosterone modulation, hyperkalaemia management, and cardiorenal therapeutics.Dr Javed Butler opens with a practical overview of aldosterone’s central role in heart failure and CKD, emphasising the importance of achieving guideline-directed RAAS inhibitor and MRA dosing. He… View more

Prevention & Chronic Conditions

Heart Failure
Hot Line Sessions Revealed for ESC Congress 2025
Added: 10 months ago Source:  ESC Congress 2025 Scientific Programme
Ten hot line sessions have been announced for ESC Congress 2025.The congress is set to take place from the 29th August to 1st September at IFEMA - Fiera de Madrid.Access the full programme here.Hot Line 1Friday 29th August, 11:00am – 12:00pm (CEST)POTCAST – a Randomized Controlled Trial of Arrhythmia prevention using targeted plasma potassium levels in ICD Patients – Presented by Christian… View more

Intervention

Vascular Disease and Surgery
Understanding the Role of GLP-1 RAs in the Treatment of HF
Author(s): Giovanni Battista Bonfioli , Matteo Pagnesi , Daniela Tomasoni , et al Added: 9 months ago

Cardiovascular Kidney Metabolic

Heart Failure
Jaikirshan Khatri
Research Area(s) / Expertise:

Carotid Artery Disease

Peripheral Intervention

Inherited and Congenital Cardiac Conditions

 Job title: Director of Complex Coronary Interventions
Personal History Dr Jaikirshan J. Khatri is a Cardiology Specialist and Director of Complex Coronary Interventions at Cleveland Clinic, Ohio. His clinical focus is on treatment of chronic total occlusions. In addition to his coronary practice, Dr Khatri performs peripheral, carotid and structural interventions and is facile in alternative access for large bore arterial catheters.7 In his… View more
Paul F Dellaripa
Research Area(s) / Expertise: Job title: Associate Professor
Personal History Dr Paul F. Dellaripa is a Rheumatologist at the Brigham and Women’s Hospital and an Associate Professor of Medicine at Harvard Medical School. He is based in Boston, Massachusetts. Academic History In 1989, Dr Dellaripa was awarded his M.D. from the University of Connecticut School of Medicine. He completed his Internal Medicine Residency (1990 - 1992) and his… View more
Amalia Peix
Job title: Full Professor & Senior Researcher
Overview Dr Amalia Peix was born in Havana, Cuba and has specialised in nuclear cardiology since 1991.1 She is currently an MD, Professor and Senior Researcher at the Institute of Cardiology and Cardiovascular Surgery in Havana, Cuba. Academic History 1974 – 1980: High Institute of Medical Sciences, Havana, Cuba. Career Overview Dr Peix is a member of the National PhD… View more
Hyperkalaemia in Acute Heart Failure: An Asian Population Study
Author(s): Wy Jin Quah , Maizatu Akma Sulong , Ghazali Ahmad , et al Added: 11 months ago

Cardiovascular Kidney Metabolic

Heart Failure
Acoramidis Reduces Cumulative CV Events in ATTR-CM
Added: 3 months ago Source:  Radcliffe Cardiology
Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive disease associated with a significant burden of recurrent cardiovascular (CV) events. A new post hoc analysis of the ATTRibute-CM trial suggests that acoramidis, an oral transthyretin (TTR) stabiliser, significantly reduces the cumulative burden of these outcomes.¹MethodologyThis exploratory analysis used data from the phase 3,… View more

Cardiovascular Kidney Metabolic

Heart Failure
Study Finds Multimorbidity Dramatically Increases Mortality Risk in Heart Failure Patients with Mildly Reduced and Preserved Ejection Fraction
Added: 1 year ago Source:  Radcliffe CVRM
A recent study published in Circulation: Heart Failure1 has found that multimorbidity, the presence of two or more chronic health conditions, substantially increases the risk of mortality in patients with heart failure who have mildly reduced (HFmrEF) or preserved ejection fraction (HFpEF).The study analyzed data from two major heart failure trials: TOPCAT-Americas (Treatment of Preserved Cardiac… View more

Prevention & Chronic Conditions

Heart Failure
GDMT & Outcomes in HFrEF: Physician-led Multicentre Experience from Sarawak
Author(s): Rebecca Su Li Chew , Bui Khiong Chung , Hwei Sung Ling , et al Added: 2 months ago

Cardiovascular Kidney Metabolic

Guidelines & Statements